<?xml version="1.0" encoding="UTF-8"?>
<p>Ustekinumab is a fully human IgG1 monoclonal antibody that inhibits the p40 subunit of both IL-12 and IL-23, rendering them unable to bind to their receptors. It has been approved for psoriasis, psoriatic arthritis, and inflammatory bowel disease (Crohnâ€™s disease, ulcerative colitis).</p>
